Cutoff | G0–1 | ≥ G2 | SEN | SPE | PPV | NPV | LR+ | LR− | Population involved (%) | Interpretation | |
---|---|---|---|---|---|---|---|---|---|---|---|
Training cohort (n = 401) | Low cutoff | 0.908 | 0.485 | 0.720 | 0.782 | 1.761 | 0.191 | 59.4 | Absence of necroinflammatory activity (78% certainty) | ||
< 0.375 | 216 | 22 | |||||||||
> 0.375 | 84 | 79 | |||||||||
High cutoff | 0.538 | 0.920 | 0.908 | 0.577 | 6.743 | 0.502 | 40.6 | Presence of necroinflammatory activity (91% certainty) | |||
< 0.720 | 128 | 110 | |||||||||
> 0.720 | 13 | 150 | |||||||||
Validation cohort (n = 401) | Low cutoff | 0.951 | 0.376 | 0.612 | 0.881 | 1.523 | 0.130 | 50.9 | Absence of necroinflammatory activity (88% certainty) | ||
< 0.375 | 194 | 10 | |||||||||
> 0.375 | 123 | 74 | |||||||||
High cutoff | 0.495 | 0.954 | 0.918 | 0.646 | 10.83 | 0.529 | 49.1 | Presence of necroinflammatory activity (92% certainty) | |||
< 0.720 | 101 | 103 | |||||||||
> 0.720 | 9 | 188 |